Refresh

Solvay Pharma India Ltd.[Amalgamated] - Research Center

532447 DUPHARPH Group (N.A.) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Dec ' 10 Dec ' 09 Dec ' 08 Dec ' 07 Dec ' 06

Sales

296.91 243.16 201.28 167.77 157.49

Operating profit

75.37 61.63 47.38 44.16 30.64

Interest

0.01 - 0.01 0.03 0.08

Gross profit

79.05 63.98 51.54 47.87 34.11

EPS (Rs)

100.69 79.26 64.96 55.68 37.09
Annual  results in details
Dec ' 10 Dec ' 09 Dec ' 08 Dec ' 07 Dec ' 06

Other income

3.69 2.35 4.17 3.74 3.56

Stock adjustment

0.73 2.19 -5.20 0.75 -3.81

Raw material

54.47 49.79 43.53 32.91 30.96

Power and fuel

- - - - -

Employee expenses

33.74 26.48 21.38 18.82 17.31

Excise

- - - - 13.39

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

132.61 103.07 94.19 71.13 69.00

Provisions made

- - - - -

Depreciation

3.20 4.57 1.33 4.97 4.59

Taxation

24.99 20.63 17.41 14.78 10.79

Net profit / loss

50.85 40.03 32.80 28.12 18.73

Extra ordinary item

- 1.25 - - -

Prior year adjustments

- - - - -

Equity capital

5.05 5.05 5.05 5.05 5.05

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

5.63 15.73 15.73 15.73 15.73

Agg.of non promotoholding (%)

11.15 31.15 31.15 31.15 31.15

OPM (%)

25.38 25.35 23.54 26.32 19.45

GPM (%)

26.30 26.06 25.09 27.91 21.18

NPM (%)

16.92 16.30 15.97 16.39 11.63
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com